According to the newly released Global Health Economics and Outcomes Research (HEOR) Market Report 2021, the industry attained a value of USD 1228 million in 2020. The market is further expected to grow in the forecast period of 2021-2026 at a CAGR of 12.5% to reach USD 2459.4 million by 2026.
The services used by healthcare and pharmaceutical companies to determine the value, cost, and cost-effectiveness of products or processes are referred to as HEOR.
Observational data, price comparison, and other market indicators assist healthcare and pharmaceutical companies in making better informed strategic decisions for their goods. HEOR assists healthcare decision-makers, such as physicians, governments, payers, health ministries, and patients, in comparing and selecting the best treatment options.
The focus of health economics and outcomes research service providers on providing optimal health outcomes for patients from an affordable perspective will increase its demand over the period, thereby facilitating the overall industry growth. The increasing drug development is driving the demand for the HEOR industry.
The overall market will rise as demand for secure services like clinical and preclinical testing, as well as regulatory affairs expertise grows. The use of healthcare IT and analytic technologies allows these CROs to coordinate across several platforms, which will drive up the need for HEOR services in payer decision-making, boosting the market for HEOR.
HEOR aid clinical development by giving useful information about specific treatments, such as population accessibility and competitor pricing. HEOR services are used to determine the price of a newly produced drug and to revise the prices of existing drugs, thereby boosting the industry’s growth.
Competitive Landscape
The report looks into the market shares, plant turnarounds, capacities, investments, and mergers and acquisitions, among other major developments, of the key players in the industry.
Some of the major players in the market explored in the report are:
IQVIA Inc.
Medpace, Inc.
Certara, Inc.
Syneos Health
McKesson Corporation
Optum, Inc
Key Topics Covered:
1 Preface
2 Report Coverage - Key Segmentation and Scope
3 Report Description
4 Key Assumptions
5 Executive Summary
6 Snapshot
7 Industry Opportunities and Challenges
8 Global Health Economics and Outcomes Research (HEOR) Market Analysis
9 Regional Analysis
10 Market Dynamics
11 Value Chain Analysis
12 Cost Analysis
13 Procurement Strategy
14 Billing Rates
15 Competitive Landscape
16 Industry Events and Developments
The report is available here